NICE backs Akcea’s Tegsedi, pipping Alnylam to hATTR okayNICE has recommended that Akcea’s hereditary transthyretin-related amyloidosis (hATTR) treatment Tegsedi be made available on the NHS in Share XNICE backs Akcea’s Tegsedi, pipping Alnylam to hATTR okayhttps://pharmaphorum.com/news/nice-backs-akceas-tegsedi-pipping-alnylam-to-hattr-okay/
4th Annual Antibody Drug Conjugates (ADC) Summit: From Target to TherapeuticsWe are pleased to invite you to the 4th Annual Antibody Drug Conjugates Summit: From Target to Therapeutics Share X4th Annual Antibody Drug Conjugates (ADC) Summit: From Target to Therapeuticshttps://pharmaphorum.com/partner-content/4th-annual-antibody-drug-conjugates-adc-summit-from-target-to-therapeutics/
3rd Annual Impurities: Genotoxic and Beyond SummitWe are pleased to invite you to the 3rd Annual Impurities: Genotoxic and Beyond Summit scheduled for June Share X3rd Annual Impurities: Genotoxic and Beyond Summithttps://pharmaphorum.com/partner-content/3rd-annual-impurities-genotoxic-and-beyond-summit/
Gene and Cell Therapy: Quality Developments to Commercialization SummitWe are pleased to invite you to the Annual Gene and Cell Therapy: Quality Developments to Commercialization Summit, Share XGene and Cell Therapy: Quality Developments to Commercialization Summithttps://pharmaphorum.com/partner-content/gene-and-cell-therapy-quality-developments-to-commercialization-summit/
3rd Annual Antibody Summit: Bispecifics & MultispecificsWe are pleased to invite you to the 3rd Annual Antibody Summit: Biscpecifics & Multispecifics scheduled for May Share X3rd Annual Antibody Summit: Bispecifics & Multispecificshttps://pharmaphorum.com/partner-content/3rd-annual-antibody-summit-bispecifics-multispecifics/
5th Annual Pre-Filled Syringes & Injectables SummitWelcome to the 5th anniversary edition of the Pre-Filled Syringes & Injectables Summit on September 18-19, 2019, in Share X5th Annual Pre-Filled Syringes & Injectables Summithttps://pharmaphorum.com/partner-content/5th-annual-pre-filled-syringes-injectables-summit/
3rd Annual Aseptic Processing SummitVonlanthen Group is pleased to invite you to the 3rd Annual Aseptic Processing Summit scheduled on November 20-21, Share X3rd Annual Aseptic Processing Summithttps://pharmaphorum.com/partner-content/3rd-annual-aseptic-processing-summit/
US drug cost body calls for SMA drug price cutsA US drug cost-effectiveness group has said that Biogen should cut the price of its already-approved spinal muscular Share XUS drug cost body calls for SMA drug price cutshttps://pharmaphorum.com/news/us-drug-cost-body-calls-for-sma-drug-price-cuts/
NICE recommends interim funding for Lilly’s breast cancer drugFinal draft guidance from NICE has recommended interim NHS funding for Eli Lilly’s Verzenios (abemaciclib) with fulvestrant, giving Share XNICE recommends interim funding for Lilly’s breast cancer drughttps://pharmaphorum.com/news/nice-recommends-interim-funding-for-lillys-breast-cancer-drug/
